505 related articles for article (PubMed ID: 26261991)
1. Extracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning.
Wolff G; Truse R; Decking U
PLoS One; 2015; 10(8):e0135086. PubMed ID: 26261991
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
Eckle T; Krahn T; Grenz A; Köhler D; Mittelbronn M; Ledent C; Jacobson MA; Osswald H; Thompson LF; Unertl K; Eltzschig HK
Circulation; 2007 Mar; 115(12):1581-90. PubMed ID: 17353435
[TBL] [Abstract][Full Text] [Related]
3. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning.
Hart ML; Much C; Gorzolla IC; Schittenhelm J; Kloor D; Stahl GL; Eltzschig HK
Gastroenterology; 2008 Nov; 135(5):1739-1750.e3. PubMed ID: 18804111
[TBL] [Abstract][Full Text] [Related]
4. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart.
Harrison GJ; Willis RJ; Headrick JP
Cardiovasc Res; 1998 Oct; 40(1):74-87. PubMed ID: 9876319
[TBL] [Abstract][Full Text] [Related]
5. Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.
Grenz A; Zhang H; Eckle T; Mittelbronn M; Wehrmann M; Köhle C; Kloor D; Thompson LF; Osswald H; Eltzschig HK
J Am Soc Nephrol; 2007 Mar; 18(3):833-45. PubMed ID: 17267736
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response.
Koszalka P; Ozüyaman B; Huo Y; Zernecke A; Flögel U; Braun N; Buchheiser A; Decking UK; Smith ML; Sévigny J; Gear A; Weber AA; Molojavyi A; Ding Z; Weber C; Ley K; Zimmermann H; Gödecke A; Schrader J
Circ Res; 2004 Oct; 95(8):814-21. PubMed ID: 15358667
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.
Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
J Clin Invest; 1994 May; 93(5):2197-205. PubMed ID: 8182151
[TBL] [Abstract][Full Text] [Related]
8. Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage.
Kitakaze M; Hori M; Takashima S; Sato H; Inoue M; Kamada T
Circulation; 1993 Jan; 87(1):208-15. PubMed ID: 8419009
[TBL] [Abstract][Full Text] [Related]
9. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812
[TBL] [Abstract][Full Text] [Related]
10. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase.
Kitakaze M; Node K; Minamino T; Komamura K; Funaya H; Shinozaki Y; Chujo M; Mori H; Inoue M; Hori M; Kamada T
Circulation; 1996 Feb; 93(4):781-91. PubMed ID: 8641008
[TBL] [Abstract][Full Text] [Related]
11. Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
Miki T; Miura T; Bünger R; Suzuki K; Sakamoto J; Shimamoto K
Am J Physiol; 1998 Oct; 275(4):H1329-37. PubMed ID: 9746483
[TBL] [Abstract][Full Text] [Related]
12. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
13. Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart.
Komamura K; Kitakaze M; Funaya H; Ueda Y; Node K; Minamino T; Kurihara T; Hori M
J Cardiovasc Pharmacol; 1997 Dec; 30(6):775-83. PubMed ID: 9436817
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity.
Minamino T; Kitakaze M; Morioka T; Node K; Komamura K; Takeda H; Inoue M; Hori M; Kamada T
Am J Physiol; 1996 Jan; 270(1 Pt 2):H238-44. PubMed ID: 8769757
[TBL] [Abstract][Full Text] [Related]
15. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning.
Toyoda Y; Di Gregorio V; Parker RA; Levitsky S; McCully JD
Circulation; 2000 Nov; 102(19 Suppl 3):III326-31. PubMed ID: 11082409
[TBL] [Abstract][Full Text] [Related]
16. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart.
McCully JD; Uematsu M; Parker RA; Levitsky S
J Thorac Cardiovasc Surg; 1998 Jul; 116(1):154-62. PubMed ID: 9671910
[TBL] [Abstract][Full Text] [Related]
17. Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis.
Peng Z; Fernandez P; Wilder T; Yee H; Chiriboga L; Chan ES; Cronstein BN
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):821-4. PubMed ID: 18600546
[TBL] [Abstract][Full Text] [Related]
18. eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.
Talukder MA; Yang F; Shimokawa H; Zweier JL
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H437-45. PubMed ID: 20525875
[TBL] [Abstract][Full Text] [Related]
19. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
20. Activation of ecto-5'-nucleotidase and cardioprotection by ischemic preconditioning.
Kitakaze M; Minamino T; Node K; Komamura K; Hori M
Basic Res Cardiol; 1996; 91(1):23-6. PubMed ID: 8660251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
